Faron Pharmaceuticals Oy

Finland

 
Total IP 89
Total IP Rank # 15,022
IP Activity Score 2.6/5.0    47
IP Activity Rank # 15,793
Stock Symbol
ISIN FI4000153309
Market Cap. 149.582M  (EUR)
Industry Biotechnology
Sector Healthcare
Dominant Nice Class Pharmaceutical, veterinary and s...

Patents

Trademarks

21 5
11 7
22 9
14
 
Last Patent 2025 - Clever-1 inhibitor for promoting...
First Patent 2003 - Common lymphatic endothelial and...
Last Trademark 2022 - BEXCLEVY
First Trademark 2007 - TRAUMAKINE

Industry (Nice Classification)

Latest Inventions, Goods, Services

2024 Invention Clever-1 inhibitor for promoting hematological recovery when using chemotherapy. The present inve...
2023 Invention Method for identifying cancer patients that benefit from anti-clever-1 treatment. A method for pr...
2022 Invention Method for using inflammatory markers to guide anti-clever-1 based cancer treatment. A method fo...
Invention Method for using inflammatory markers to guide anti-clever-1 cancer treatment. A method for choos...
G/S Pharmaceuticals; medical preparations; veterinary preparations; sanitary preparations for medical...
G/S Pharmaceuticals; medical preparations; veterinary preparations; sanitary preparations for medica...
G/S Pharmaceuticals used for the prevention and treatment of cancer, bone marrow dysfunction or suppr...
Invention Stable anti-clever-1 antibody formulation. The invention relates to stable formulations comprisi...
G/S Pharmaceuticals; Medical preparations; Veterinary preparations; Sanitary preparations for medical...
Invention Treatment of diseases with sequential administration of an agent capable of up-regulating cd73 an...
Invention Controlling of immune activation by soluble clever-1. Altering levels of soluble CLEVER- 1 in cir...
Invention Controlling of immune activation by soluble clever-1. Altering levels of soluble CLEVER-1 in cir...
2021 Invention Stable anti-clever-1 antibody formulation. The invention relates to stable formulations comprisin...
Invention Humanized anti clever-1 antibodies and their use. This invention relates to an agent and a human...
Invention Treatment of diseases with clever-1 inhibition in combination with an interleukin inhibitor. Use...
Invention Treatment of diseases with clever-1 inhibition in combination with an interleukin inhibitor. Use ...
G/S Chemicals for use in industry, science and photography, as well as in agriculture, horticulture a...
G/S Chemicals for use in industry, science and photography, as well as in agriculture, horticulture ...
G/S Chemicals preparations for use in the manufacture of pharmaceutical and biotechnological industry...
Invention Method for promoting expansion of hematopoietic stem cells and agent for use in the method. A va...
Invention Method for promoting expansion of hematopoietic stem cells and agent for use in the method. A vas...
Invention Method for promoting expansion of hematopoietic stem cells and agent for use in the method. ex vi...
2020 Invention Anti-clever-1 agents for controlling the expression of cell surface markers on leucocytes, and us...
Invention Anti-clever-1 agents for controlling lysosomal vatpase proton pumps to increase lysosomal ph-valu...
Invention Method for determining potency of therapeutic anti-clever-1 antibody. A method for determining a...
Invention Method for determining potency of therapeutic anti-clever-1 antibody. A method for determining a ...
G/S Pharmaceuticals for treatment of diseases and disorders of blood and blood forming organs; Pharma...
G/S Pharmaceutical preparations for treatment and prevention of ischemic conditions resulting from ti...
G/S Pharmaceutical, veterinary and sanitary preparations.
2019 Invention Method for determining patient's responsiveness to type 1 interferon treatment and use of type 1 ...
Invention Method for determining patient's responsiveness to type i interferon treatment and use of type i ...
Invention Tlr9 agonists for use in downregulating clever-i expression on alternatively activated macrophage...
Invention Tlr9 agonists for use in downregulating clever-1 expression on alternatively activated macrophage...
Invention Treatment of cancer with clever-1 inhibition in combination with pd-1/pd-l1 inhibitor. The inven...
Invention Treatment of cancer with clever-1 inhibition in combination with pd-1/pd-l1 inhibitor. The invent...
2018 G/S Pharmaceutical research and development; Development of pharmaceutical preparations and medicines...
2017 G/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes.
G/S Pharmaceuticals, medical and veterinary preparations for the treatment of diseases and disorders...
Invention Humanized anti clever-1 antibodies and their use. This invention relates to an agent and a humani...
Invention Method of monitoring the efficacy of the anti-clever-1 therapy in cancer. An agent capable of bin...
Invention Diagnosis of immune_activation using clever-1, tnf-alpha and hla-dr binding agents. An agent capa...
Invention Agents recognizing clever-1 epitope and uses thereof. This invention relates to an agent and a hu...
G/S Pharmaceuticals, medical and veterinary preparations for the treatment of diseases and disorders ...
G/S Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes.
Invention A lyophilised pharmaceutical formulation and its use. A pharmaceutical formulation in a lyophilis...
2016 Invention Lyophilised pharmaceutical formulation and its use. A pharmaceutical formulation in a lyophilised...
G/S Pharmaceutical preparations; Veterinary preparations; Sanitary preparations for medical purposes.
2015 G/S Medical and veterinary preparations and articles, namely, isotopes for medical purposes, hormones...
G/S Medical and veterinary preparations and articles; Pharmaceutical preparations for the treatment o...
2014 Invention Cell and therapeutical and diagnostical methods based thereon. The invention relates to a novel c...
Invention Method for determining acute respiratory distress syndrome (ards) related biomarkers, a method to...
Invention A method for determining acute respiratory distress syndrome (ards) related biomarkers, a method ...
2013 Invention Biomarker for monitoring development of diseases and assessing the efficacy of therapies. The inv...
2010 Invention A novel cell and therapeutical and diagnostical methods based thereon. The invention relates to a...